Revenue: The sum of all revenue fields included for a company's operating activities.
ESSA Pharma Inc. (EPIX) Revenue data is not available for the most recently reported fiscal year, ending 2024-09-30.
| Income Statement Financials | |
|
Revenue |
-- |
$-28.54M |
|
-- |
|
-- |
|
$34.42M |
|
$-34.42M |
|
$5.88M |
|
$-28.54M |
|
$-28.54M |
|
$-28.54M |
|
$-28.54M |
|
$-28.54M |
|
$-28.54M |
|
$-34.42M |
|
$-34.33M |
|
44.28M |
|
44.28M |
|
$-0.64 |
|
$-0.64 |
|
| Balance Sheet Financials | |
$127.56M |
|
-- |
|
$0.55M |
|
$128.11M |
|
$3.30M |
|
-- |
|
$0.21M |
|
$3.51M |
|
$124.61M |
|
$124.61M |
|
$124.61M |
|
44.39M |
|
| Cash Flow Statement Financials | |
$-22.72M |
|
$91.79M |
|
$0.93M |
|
$33.70M |
|
$103.71M |
|
$70.01M |
|
$6.54M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
38.64 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-22.72M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-22.91% |
|
-22.91% |
|
-22.28% |
|
-22.91% |
|
$2.81 |
|
$-0.51 |
|
$-0.51 |
|